Product Information
CEQUA 0.09% SOLUTION is a brand product labeled by Sun Pharmaceutical Industries Inc., priced at $10.3828 per EA under NDC 47335050696. Its NADAC has been published 342 times since Mar 18, 2020.
FDA first approved this application on Aug 14, 2018.
Strength
.0009 g/mL
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
47335050696
Classification
Brand
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC; TOPICAL
Effective Date
9/23/2026
Active Ingredients
CYCLOSPORINEApproval Type
New Drug (NDA)
FDA Application
NDA210913FDA Approved
8/14/2018
On Market Since
8/15/2018
Pharmacological Classes
Price Statistics
The NADAC for CEQUA 0.09% SOLUTION has been published 342 times since Mar 18, 2020, and over the history we have for it it has risen 27.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.3828 per EA |
|---|---|
| All-time high | $10.3843 (Jul 15, 2026) |
| All-time low | $8.1097 (Dec 23, 2020) |
| 52-week high | $10.3843 |
| 52-week low | $10.0532 |
| Median price | $8.9448 |
| Average price | $9.1294 |
| Largest weekly change | +7.5% (Jan 15, 2025) |
| Weeks tracked | 342 |
| Tracking since | Mar 18, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the cyclosporine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sun Pharmaceutical Industries Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
cyclosporine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Calcineurin Inhibitor Immunosuppressant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CEQUA 0.09% SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for CEQUA 0.09% SOLUTION, manufactured by Sun Pharmaceutical Industries Inc., is $10.3828 per EA (NDC 47335050696), effective Sep 30, 2026.
How has the price of CEQUA 0.09% SOLUTION changed over time?
Over the history we have for it, the NADAC for CEQUA 0.09% SOLUTION has risen 27.7%. It has been tracked across 342 weekly CMS publications since Mar 18, 2020.
What are the highest and lowest recorded NADAC prices for CEQUA 0.09% SOLUTION?
Since Mar 18, 2020, the NADAC for CEQUA 0.09% SOLUTION has ranged from a low of $8.1097 (Dec 23, 2020) to a high of $10.3843 (Jul 15, 2026), with a median of $8.9448 per EA.
Are there cheaper alternatives to CEQUA 0.09% SOLUTION?
No other NADAC-published product currently shares the active ingredient and strength of CEQUA 0.09% SOLUTION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CEQUA 0.09% SOLUTION?
CEQUA 0.09% SOLUTION (NDC 47335050696) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a brand product.